Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Wedbush PacGrow Healthcare Conference taking place in New York City, New York on Tuesday, August 13, 2024, at 11 AM ET.

About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.

Investor Contact
ir@compasstherapeutics.com

Media Contact
Anna Gifford, Senior Communications Manager
media@compasstherapeutics.com
617-500-8099

Staff

Recent Posts

Asentech Named PM360 Trailblazer Award Finalist for App/Digital Solution Category

NEW YORK CITY, NY / ACCESSWIRE / August 18, 2024 / PM360, a monthly magazine…

8 hours ago

2024 World Life Science Conference Scheduled for October 19 in Hainan, China

BEIJING, Aug. 18, 2024 /PRNewswire/ -- On August 10, the third press conference for the…

14 hours ago

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the…

17 hours ago

Life Rx Celebrates Helping 35,000 Patients Achieve Wellness Success

CHERRY HILL, NJ / ACCESSWIRE / August 17, 2024 / LifeRx, a leading provider of…

2 days ago

Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders

COPENHAGEN, Denmark, August 17, 2024 – Bavarian Nordic A/S (OMX: BAVA) provides an update on…

2 days ago

Matt Oldford, the Founder of Matty Renos, Unveils New Website to Enhance Client Experience in Nova Scotia

Dartmouth, Nova Scotia--(Newsfile Corp. - August 17, 2024) - Matty Renos, a leading renovation and…

2 days ago